Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
myocardial perfusion imaging
MeSH D055414 - myocardial perfusion imaging
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D057791:
Cardiac imaging techniques
0 Companies
0 Drugs
Success rate
D055420:
Perfusion imaging
0 Companies
0 Drugs
Success rate
D006334:
Heart function tests
0 Companies
0 Drugs
Success rate
D055414:
Myocardial perfusion imaging
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
GE Healthcare
Regadenoson
Rapiscan
2010-09-06
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/1
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GE Healthcare
Regadenoson
,
Bolus
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use